Powder: -20°C for 3 years | In solvent: -80°C for 1 year
EIDD-2749 (4'-Fluorouridine), an orally active RdRp inhibitor, effectively inhibits the replication of RSV and SARS-CoV-2. It also demonstrates activity against HCV and lymphocytic choriomeningitis virus (LCMV), highlighting its potential as an oral therapeutic candidate for COVID-19 and its utility in research on various RNA viruses.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 35 days | $ 98.00 | |
10 mg | 35 days | $ 180.00 | |
25 mg | 35 days | $ 392.00 | |
50 mg | 35 days | $ 748.00 |
Description | EIDD-2749 (4'-Fluorouridine), an orally active RdRp inhibitor, effectively inhibits the replication of RSV and SARS-CoV-2. It also demonstrates activity against HCV and lymphocytic choriomeningitis virus (LCMV), highlighting its potential as an oral therapeutic candidate for COVID-19 and its utility in research on various RNA viruses. |
Synonyms | 4'-Fluorouridine, 4'-FlU ; 4'-Fluorouridine, 4'-FlU |
Molecular Weight | 262.19 |
Formula | C9H11FN2O6 |
CAS No. | 1613589-24-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
EIDD-2749 1613589-24-4 4'-Fluorouridine 4'-FlU ; 4'-Fluorouridine 4'-FlU EIDD 2749 4'-FlU ; 4'-Fluorouridine EIDD2749 inhibitor inhibit